PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Renal cancer drug temsirolimus shows promise against mesothelioma

2011-05-01
(Press-News.org) Denver, Colo. (May 1, 2011) -- A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

Temsirolimus, a kinase inhibitor, blocks the action of mammalian target of rapamycin (mTOR), a protein that regulates cell growth, which can slow tumor growth. It's used to treat advanced renal cell carcinoma.

But researchers in Austria have found that temsirolimus also may slow the growth of malignant pleural mesothelioma cells. Mesothelioma, a cancer that is usually caused by exposure to asbestos and may not appear until 30 to 50 years after exposure, frequently resists chemotherapy and radiation treatment.

The researchers found that temsirolimus strongly blocked mTOR-mediated signals and had a cytostatic, or growth-stopping, effect on all mesothelioma cells. However, mesothelioma cells that were resistant to cisplatin, a widely used chemotherapy drug, showed hypersensitivity against temsirolimus.

That suggests that mTOR inhibitors like temsirolimus might be a promising treatment strategy either in combination with chemotherapy or as second-line treatment after chemotherapy failure.

"Malignant mesothelioma is a severe human malignancy characterized by a very bad prognosis, with a mean patient survival time of less than one year," said Professor Walter Berger, PhD, of the Institute of Cancer Research at the Medical University of Vienna. "This unacceptable situation is mainly caused by late diagnosis combined with a distinct resistance to all forms of systemic therapy available so far. Mesothelioma is frequently caused by asbestos exposure and unfortunately -- based on the long latency period -- the incidence peak lies, despite the ban on asbestos, still ahead. Consequently, novel therapeutic options for this devastative disease are urgently needed.

"In our preclinical study, published in the JTO, we were able to demonstrate that inhibition of the major oncogene mTOR is active against human mesothelioma especially after development of chemotherapy resistance both in vitro and in vivo," Berger said. "These results suggest the initiation of clinical trials involving mTOR inhibitors as a novel anti-mesothelioma strategy."

###

The study was supported by the Medical Scientific Fund of the Mayor of the City of Vienna, Initiative Krebsforschung of the Medical University Vienna, and a Wyeth/Pfizer research grant.

About the Journal of Thoracic Oncology:

The Journal of Thoracic Oncology (JTO) is the official monthly journal of the International Association for the Study of Lung Cancer (IASLC). It is a prized resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer. It emphasizes a multidisciplinary approach, including original research (clinical trials and translational or basic research), reviews and opinion pieces. To learn more about the JTO please visit http://journals.lww.com/jto/pages/default.aspx.

About the IASLC:

The Denver-based International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1972, the association's membership includes more than 3,000 lung cancer specialists in 80 countries.

IASLC members promote the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer and thoracic malignancies. IASLC disseminates information about lung cancer to scientists, members of the medical community and the public, and uses all available means to eliminate lung cancer as a health threat for the individual patients and throughout the world. Membership is open to any physician, health professional or scientist interested in lung cancer.

To learn more about IASLC please visit http://iaslc.org/

END



ELSE PRESS RELEASES FROM THIS DATE:

New material could improve safety for first responders to chemical hazards

New material could improve safety for first responders to chemical hazards
2011-05-01
A new kind of sensor could warn emergency workers when carbon filters in the respirators they wear to avoid inhaling toxic fumes have become dangerously saturated. In a recent issue of the journal Advanced Materials, a team of researchers from the University of California, San Diego and Tyco Electronics describe how they made the carbon nanostructures and demonstrate their potential use as microsensors for volatile organic compounds. First responders protect themselves from such vapors, whose composition is often unknown, by breathing through a canister filled with ...

Hawaii Food and Wine Festival - 50% Discount Monday

2011-05-01
There has been numerous requests from Hawaii residents for a kama'aina discount for the "Invitation To Foodies" culinary seminar at the Makena Beach and Golf Resort on Maui. This seminar benefits three Maui non-profits. The non-profits are the Friends of the Children's Justice Center of Maui, Haku Baldwin Center and Ka Lima O Maui. As sponsors of the event, TasteHawaiiOnline.com had to first consider how a discount would affect the quality of the seminar, the lecturers, the presentations and the food. Local chef personalities are asked to share their knowledge ...

National Foster Care Month

2011-05-01
Each May, since 1988, National Foster Care Month has raised awareness for millions of Americans across the country. Originally purposed to recognize and show appreciation to foster parents throughout the nation, National Foster Care Month has transferred that focus towards the needs of the children, specifically the teenagers, aging out of the system. Today, National Foster Care Month continues to broaden awareness, uniting individuals and organizations through strong support and recruitment programs nationwide. When parents can not keep their children due to crisis, ...

Polaris Grows 9% Q-o-Q; Quarterly Revenues Poised to Cross $100 million

2011-05-01
Polaris Software Lab Limited (POLS.BO), a leading global Financial Technology company, today announced the fourth quarter and annual results for FY 2010-11. The company delivered strong and stable results led by impressive product wins, multiple large engagements with leading Tier 1 global banks & financial institutions and further consolidated its market presence in key business geographies. Key Performance metrics For the quarter ended 31 March 2011, Revenue grew by 9% Q-o-Q to Rs. 437.53 crore from Rs. 399.9 crore and 25% Y-o-Y to Rs. 437.53 crore from Rs. 351.04 ...

Adrian Flux See Wedding Wheels Get More Weird and Wonderful

2011-05-01
From tanks to taxis and tuk-tuks to time-travelling Deloreans, happy couples are no longer content, it seems, to ride off into the sunset in a white limo or a vintage Rolls. These days, it's as much about making a statement as getting to the church on time. After all, what is a wedding for if it's not to attract attention? Well, that and ever-lasting love, of course... While Kate will arrive at Westminster Abbey in the 1977 Rolls-Royce that was damaged by protesters in London in December, and depart as a Duchess in the horse-drawn carriage used by Charles and Diana, ...

Small Business Economic Impact Alliance is Reducing Red Tape!

2011-04-30
The Small Business Economic Impact Alliance announced today their support for the "Red Tape" legislative bill SB 951, introduced by California Senator Ted Gaines. This bill takes a comprehensive approach to reducing the financial burden on California businesses, particularly small businesses, brought about by over-regulation. If it passes, SB 951 will require all state agencies to review their current regulations and reduce the number of existing regulations by one-third. In addition, the bill will have an impact on future regulations in two ways. First, it ...

Dr. Kevin Sadati to Speak at the 95th Annual Clinical Assembly of the AOCOO-HNS/Facial Plastic Surgery

2011-04-30
By special invitation from The American Osteopathic Colleges of Ophthalmology and Otolaryngology-Head and Neck Surgery, Dr. Kevin Sadati has been asked to speak on his inimitable 'Double-C Plication' Facelift technique. Dr. Sadati's paper on his special technique was recently published by The American Journal of Cosmetic Surgery to very positive feedback from his peers. This year, the 95th Annual Clinical Assembly of the AOCOO-HNS/Facial Plastic Surgery will be held in Tucson, Arizona on May 6, 2011. Dr. Sadati has been asked to speak at several prestigious medical conventions ...

Linbeck Group, LLC Wins Associated General Contractors of America's Aon Build America Award for Best New Building Project Under $10 Million of 2010

2011-04-30
Texas Christian University's (TCU) Mary Wright Admission Center in Fort Worth was one of the most significant construction projects of 2010, the Associated General Contractors of America announced today. As a result, the project's contractor, Linbeck Group, LLC, was one of 20 firms to receive the association's Aon Build America Award. "We are honored to be acknowledged by our peers in receiving this award," said Harold Hebson, Client Executive and Senior Vice President for the Linbeck Group. "We want to thank TCU for making this project possible and all collaborators ...

Diamond & Design Jewelers Holds Charity Event For St. Jude's Children's Hospital

2011-04-30
Diamond & Design Jewelers will hold a fundraising event on Saturday, April 30th at The Commons in Chino Hills to raise $5,000 for St. Jude's Children's Hospital. The event will include an exciting raffle for a $3,000 diamond ring and gift cards from popular local restaurants. Guests will enjoy live entertainment, free food, and drinks. Jewelry is available for sale during the event, with 10% of the sale benefiting St. Jude's Children's Hospital. The event will be held from 2:00 p.m. through 6:00 p.m.. St. Jude's Children's Hospital is the #1 cancer hospital for ...

Wizard World Inc. Announces Los Angeles Comic Con

2011-04-30
Gareb Shamus, President and CEO of Wizard World, Inc. (WIZD)("Wizard World"), today announced the addition of a Los Angeles Comic Con to Wizard World's 2011 lineup. The show will take place on Sept. 24-25, 2011 at the Los Angeles Convention Center. Superstar Mike Deodato Jr. is the first guest of honor at the event. The Brazilian artist, well known for his work on The Amazing Spider-Man, Captain America, The Mighty Thor, Wolverine, X-Men, The Avengers, and Batman, will be making a rare U.S. appearance. "We are ecstatic to come to the rejuvenated downtown ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Renal cancer drug temsirolimus shows promise against mesothelioma